ES2409554T3 - Composición para administración transdérmica - Google Patents
Composición para administración transdérmica Download PDFInfo
- Publication number
- ES2409554T3 ES2409554T3 ES08777444T ES08777444T ES2409554T3 ES 2409554 T3 ES2409554 T3 ES 2409554T3 ES 08777444 T ES08777444 T ES 08777444T ES 08777444 T ES08777444 T ES 08777444T ES 2409554 T3 ES2409554 T3 ES 2409554T3
- Authority
- ES
- Spain
- Prior art keywords
- administration
- composition
- present compound
- disease
- preparation example
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007163692 | 2007-06-21 | ||
| JP2007163692 | 2007-06-21 | ||
| PCT/JP2008/061300 WO2008156160A1 (fr) | 2007-06-21 | 2008-06-20 | Composition destinée à être administrée par voie transdermique ou transmucosale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2409554T3 true ES2409554T3 (es) | 2013-06-27 |
Family
ID=40156318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES08777444T Active ES2409554T3 (es) | 2007-06-21 | 2008-06-20 | Composición para administración transdérmica |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20100137429A1 (fr) |
| EP (1) | EP2158908B1 (fr) |
| JP (1) | JP5754885B2 (fr) |
| KR (1) | KR101500022B1 (fr) |
| CN (1) | CN101677988A (fr) |
| AU (1) | AU2008264476B2 (fr) |
| CA (1) | CA2690945C (fr) |
| DK (1) | DK2158908T3 (fr) |
| ES (1) | ES2409554T3 (fr) |
| IL (1) | IL202221A (fr) |
| PT (1) | PT2158908E (fr) |
| SI (1) | SI2158908T1 (fr) |
| WO (1) | WO2008156160A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5820207B2 (ja) | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
| JP5820206B2 (ja) * | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
| KR102198540B1 (ko) * | 2015-11-25 | 2021-01-06 | 삼성전기주식회사 | 적층 세라믹 커패시터 및 그 실장 기판 |
| RU2767410C2 (ru) * | 2017-03-24 | 2022-03-17 | Интра-Селлулар Терапиз, Инк. | Новые композиции и способы |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4943435A (en) * | 1987-10-05 | 1990-07-24 | Pharmetrix Corporation | Prolonged activity nicotine patch |
| GB8807504D0 (en) * | 1988-03-29 | 1988-05-05 | Sandoz Ltd | Improvements in/relating to organic compounds |
| US5879690A (en) * | 1995-09-07 | 1999-03-09 | Perricone; Nicholas V. | Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers |
| PT957080E (pt) | 1997-08-07 | 2006-10-31 | Fujimoto Brothers Co Ltd | Novos derivados de etilamina |
| JP4499208B2 (ja) * | 1998-10-29 | 2010-07-07 | 株式会社フジモト・コーポレーション | 新規な光学活性アミノペンタン誘導体 |
| KR100674108B1 (ko) * | 1999-04-13 | 2007-01-26 | 히사미쓰 세이야꾸 가부시키가이샤 | 경피흡수형 제제 |
| DE19934592C2 (de) | 1999-07-23 | 2003-10-23 | Benckiser Nv | Vorrichtung zur Aufnahme und dosierten Abgabe einer aktiven Zusammensetzung in eine Waschmaschine, einen Wäschetrockner oder eine Geschirrspülmaschine |
| NZ525551A (en) * | 2000-10-26 | 2005-09-30 | Alza Corp | Transdermal drug delivery devices having coated microprotrusions |
| US20020192821A1 (en) * | 2001-05-22 | 2002-12-19 | Active Pass Pharmaceuticals, Inc. | Increased functional activity and/or expression of ABC transporters protects against the loss of dopamine neurons associated with Parkinson's disease |
| JP4953040B2 (ja) | 2001-09-19 | 2012-06-13 | 株式会社フジモト・コーポレーション | アポトーシス抑制剤 |
| US7429258B2 (en) * | 2001-10-26 | 2008-09-30 | Massachusetts Institute Of Technology | Microneedle transport device |
| JP5030194B2 (ja) * | 2004-11-25 | 2012-09-19 | 国立大学法人九州大学 | 薬物依存症治療剤 |
| WO2006082888A1 (fr) | 2005-02-03 | 2006-08-10 | Kyorin Pharmaceutical Co., Ltd. | Preparation pour absorption percutanee |
-
2008
- 2008-06-20 ES ES08777444T patent/ES2409554T3/es active Active
- 2008-06-20 CN CN200880021157A patent/CN101677988A/zh active Pending
- 2008-06-20 EP EP08777444.4A patent/EP2158908B1/fr active Active
- 2008-06-20 CA CA2690945A patent/CA2690945C/fr not_active Expired - Fee Related
- 2008-06-20 DK DK08777444.4T patent/DK2158908T3/da active
- 2008-06-20 AU AU2008264476A patent/AU2008264476B2/en not_active Ceased
- 2008-06-20 SI SI200830982T patent/SI2158908T1/sl unknown
- 2008-06-20 JP JP2009520548A patent/JP5754885B2/ja not_active Expired - Fee Related
- 2008-06-20 US US12/452,239 patent/US20100137429A1/en not_active Abandoned
- 2008-06-20 WO PCT/JP2008/061300 patent/WO2008156160A1/fr not_active Ceased
- 2008-06-20 KR KR1020097026617A patent/KR101500022B1/ko not_active Expired - Fee Related
- 2008-06-20 PT PT87774444T patent/PT2158908E/pt unknown
-
2009
- 2009-11-19 IL IL202221A patent/IL202221A/en active IP Right Grant
-
2012
- 2012-08-13 US US13/572,987 patent/US20130005800A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2158908A1 (fr) | 2010-03-03 |
| EP2158908A4 (fr) | 2011-03-30 |
| KR20100023884A (ko) | 2010-03-04 |
| US20130005800A1 (en) | 2013-01-03 |
| CA2690945A1 (fr) | 2008-12-24 |
| AU2008264476B2 (en) | 2013-03-28 |
| DK2158908T3 (da) | 2013-07-29 |
| WO2008156160A1 (fr) | 2008-12-24 |
| KR101500022B1 (ko) | 2015-03-06 |
| IL202221A (en) | 2017-04-30 |
| AU2008264476A1 (en) | 2008-12-24 |
| US20100137429A1 (en) | 2010-06-03 |
| IL202221A0 (en) | 2010-06-16 |
| JP5754885B2 (ja) | 2015-07-29 |
| CN101677988A (zh) | 2010-03-24 |
| EP2158908B1 (fr) | 2013-04-24 |
| SI2158908T1 (sl) | 2013-07-31 |
| CA2690945C (fr) | 2015-07-21 |
| HK1139052A1 (en) | 2010-09-10 |
| PT2158908E (pt) | 2013-05-07 |
| JPWO2008156160A1 (ja) | 2010-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12144808B2 (en) | Compositions and methods | |
| ES2318233T3 (es) | Sistemas mejoradores de la penetracion y reductores de la irritacion que comprenden testosterona. | |
| EP3388417A1 (fr) | Promédicaments hydrosolubles positivement chargés d'acétaminophène et de composés associés à vitesse de pénétration cutanée très élevée | |
| CN101528211B (zh) | 眼用经皮吸收型制剂 | |
| PT1962817E (pt) | Administração transdérmica de uma forma de sal de meptazinol | |
| ES2643643T3 (es) | Composición portadora para suministro de un compuesto biológicamente activo | |
| ES2700473T3 (es) | Biodisponibilidad cerebral mejorada de galantamina mediante formulaciones seleccionadas y administración transmucosa de profármacos lipofílicos | |
| US12128027B2 (en) | N—N-dimethyltryptamine (DMT) and DMT analog compositions, methods of making, and methods of use thereof | |
| EP4028021B1 (fr) | Utilisation de nmn pour la prévention et/ou le traitement de la douleur et compositions correspondantes | |
| ES2529235T3 (es) | Formulaciones farmacéuticas que contienen palmitoil-etanolamida y estearoil-etanolamida | |
| CN101500983A (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性二氟尼柳及相关化合物的前药 | |
| ES2409554T3 (es) | Composición para administración transdérmica | |
| US20080176913A1 (en) | Transdermal compositions of pramipexole having enhanced permeation properties | |
| JP2001199883A (ja) | 消炎鎮痛外用剤 | |
| ES2516704T3 (es) | Sal ácida de tolterodina con una estabilidad eficaz para un sistema de administración transdérmica de fármacos | |
| ES2880399T3 (es) | Biodisponibilidad cerebral mejorada de galantamina mediante formulaciones seleccionadas y administración transmucosa de profármacos lipofílicos | |
| CN104367566A (zh) | 一种吲哚美辛巴布剂及其组合物 | |
| HK1139052B (en) | Composition for transdermal administration | |
| JP6676329B2 (ja) | 口腔粘膜投与用の唾液分泌促進用医薬組成物 | |
| EP2978435B1 (fr) | Utilisation du mélange d'un sel et d'un sucre dans la fabrication d'un médicament utilisé pour traiter le syndrome du vagin relâché | |
| ES2692663T3 (es) | Método y composición farmacéutica mejorada para mejorar la entrega transdérmica del inhibidor PDE-5 | |
| JP6566707B2 (ja) | 経皮唾液腺投与用の唾液分泌促進剤 | |
| BR102017011377A2 (pt) | composição e formulação tópica anestésica e seu uso | |
| CN105439877B (zh) | 带正电荷的水溶性二氟尼柳及相关化合物的前药 | |
| WO2001082915A2 (fr) | Administration transclitoridienne d'un traitement |